Table 2_Induction immunochemotherapy followed by concurrent chemoradiotherapy improves sur

A systematic review and meta-analysis of 69 trials involving 9,648 participants evaluates immunotherapy strategies for unresectable esophageal cancer. Xuefei Fan published the results on figshare in May 2026. The dataset likely contains statistical outcomes comparing overall survival, progression-free survival, objective response rate, and safety across different treatment regimens.

Use Cases

• Compare overall survival hazard ratios between induction immunochemotherapy plus CCRT and CCRT alone based on the meta-analysis results
• Analyze progression-free survival benefits of CCRT plus consolidation immunotherapy based on pairwise and network meta-analysis findings
• Rank treatment efficacy for unresectable esophageal cancer based on network meta-analysis results for OS and PFS
• Assess the safety profiles of different immunotherapy combinations with chemoradiotherapy based on the included trial data

Strengths

• Analysis is based on 69 trials (30 single-arm, 39 controlled) providing a substantial evidence base
• Includes results from both pairwise and network meta-analyses for multiple endpoints (OS, PFS, ORR, safety)
• Dataset is openly licensed under CC-BY-4.0 for reuse

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• The authors note a lack of sufficient randomized controlled trials to validate efficacy and determine optimal timing

Provenance

Source

figshare

Collection Method

Systematic review, pairwise meta-analysis, and network meta-analysis of published clinical trials

Freshness

Last updated 2026-05-12 05:42:55; freshness should be verified